We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immupharma Plc | LSE:IMM | London | Ordinary Share | GB0033711010 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.14 | 6.91% | 2.165 | 2.05 | 2.28 | 2.29 | 1.995 | 2.00 | 4,381,830 | 16:35:17 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.81M | -0.0114 | -1.93 | 7.33M |
Date | Subject | Author | Discuss |
---|---|---|---|
14/4/2020 07:59 | Hatetrader1.....is a scammer. Same link on multiple boards. Do not click on link. Joint ADVFN on the 10.4.20 | flavio_monteiro | |
10/4/2020 10:24 | Interesting article concerning role of Immune system. | colsmith | |
09/4/2020 22:47 | I missed it at 60 p | amaretto1 | |
09/4/2020 22:46 | Retirement maker ! :-)) | amaretto1 | |
08/4/2020 11:19 | Hi Nobby, what is your view on ncyt ? | scrabster1 | |
06/4/2020 07:13 | Good move .. good company ! RNS Out ! | amaretto1 | |
05/4/2020 21:31 | TR1 – Notification of major interest in shares by Lanstead Capital – 3 April 2020 3rd April 2020 - 3:13 pm | centprocent | |
02/4/2020 15:21 | Apologies it does move in trading hours. Now 9.14/11.45. So one side does, at least !! | daveboy1 | |
02/4/2020 13:22 | Purely a trade assuming Avion would get FDA approval for the trial. Looks like I might be waiting a while.... | nobbygnome | |
02/4/2020 13:20 | Not sure how - 9.58/11.45 on IG. Never budges (until 5pm). Bandits. | daveboy1 | |
02/4/2020 09:02 | Oh thanks. | glennrcharles | |
02/4/2020 08:56 | hes just trading.. | brad44 | |
02/4/2020 08:55 | Just looked back in after months away. Cant understand why Nobby is still a share holder. Just a trade or do you really think this is an investment? | glennrcharles | |
30/3/2020 09:06 | Unlike most posters I am more than happy to admit I was wrong so apologies! However, a peptide approach is unlikely to work due to half-life issues IMHO. If you think about the potential number of virus particles and the half-life of only hours for peptides, you would have to give heroic amounts of peptide to get a high enough blood concentration over a period of time. Not impossible but it would involve a lot of injections! | nobbygnome | |
30/3/2020 09:05 | Done well to get this away in these markets, they must like it. | montyhedge | |
30/3/2020 08:51 | This what i was talking about last weekBefore i was shot down.. being called a idiot ! | amaretto1 | |
30/3/2020 08:09 | Has anyone spotted buried in the middle of the statement that Ureca pharma its subsidiary has become a partner in a consortium to develop a drug to block the fusion of covid 19 im no expert but surely that's good news. | victor2 | |
30/3/2020 07:54 | Not sure .. u can come out with a statement like that... pandemic was known before Xmas .. or was going to be a real possibility The markets started reacting mid March. | amaretto1 | |
30/3/2020 07:46 | The advisory board should have happened in January/February when the pandemic was not an issue. It is the first thing you do to get the advice of experts concerning the design of your trial. I used to be involved in exactly those sort of meetings.... | nobbygnome | |
30/3/2020 07:33 | U noticed we have a world pandemic ? | amaretto1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions